Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

China State Council Unveils Pro-Pharma Policies, But Will They Work?

This article was originally published in PharmAsia News

Executive Summary

In a new policy push, China's Cabinet has listed major goals to propel the country to become the next destination for pharma innovation, with antibodies, therapeutic vaccines and peptides among the priority fields. But doubts remain given scant details on how regulators will work together to achieve the lofty goals.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register